Kaiser Permanente Ventures
Profile, fund size and portfolio
Kaiser Permanente Ventures is the corporate venture arm of Kaiser Permanente (integrated health care delivery and health plan). It was founded in 1998 and is based in Oakland, United States. It invests from Series B to Series C+ in health information technology, digital health, healthcare services.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series B to Series C+ |
| Sectors | Health information technology, Digital health, Healthcare services, Medical devices, Diagnostics and precision medicine |
| Geography | North America |
| Offices | Oakland, United States |
Sources: S1 Kaiser Permanente Ventures home (address); S2 Kaiser Permanente Ventures About Us; S5 Permanente Medicine: KPV closes Fund V with $141 million (5 Dec 2019).
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Information Technology | 28 | 39.4% |
| Services | 20 | 28.2% |
| Therapeutics | 13 | 18.3% |
| Diagnostics & Drug Delivery | 10 | 14.1% |
A company can carry more than one tag
Sources: S4 Kaiser Permanente Ventures portfolio (Category and Status filters).
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | USD 500M+ | Assets under management | Stated by the firm or its parent | S5 |
| Companies backed | 70+ | companies | Stated by the firm | S5 |
| M&A exits | 20 | exits | Stated by the firm | S4 |
| Companies on the firm's portfolio page | 71 | companies | Counted from the firm's own list | S4 |
Sources: S5 Permanente Medicine: KPV closes Fund V with $141 million (5 Dec 2019); S4 Kaiser Permanente Ventures portfolio (Category and Status filters).
Where it invests and who leads it
Geography
- Headquarters
- Oakland, United States
- Offices
- Oakland, United States
Investment regionsS1S2S5
- North America
LeadersS3
- Amy Belt RaimundoSenior Vice President & Managing DirectorLinkedInFirm page
- Brian WojtowiczExecutive DirectorFind on LinkedInFirm page
- Daniel van den BerghSenior Investment DirectorLinkedInFirm page
- Chris GrantCo-Founder & Chief Operating Officer and Executive Vice President, The Permanente Federation LLCLinkedInFirm page
- Jin ZhangPrincipalFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Kaiser Permanente | Single source | S5 |
| Parent industry | Integrated health care delivery and health plan | Single source | S5 |
| Founded | 1998 | Single source | S5 |
| Headquarters | Oakland, United States | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent and outside investors | Single source | S5 |
| Headline size | USD 500M+ (Assets under management) | Single source | S5 |
| Companies backed | 70+ | Single source | S5 |
| Exits | 48 total, 20 M&A | Single source | S4 |
| People on the team page | 7 | Single source | S3 |
| Stages | Series B, Series C+ (inferred from announced rounds) | Estimate | S1 |
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
| Company | Type | Year | Acquirer or exchange | Price | Source |
|---|---|---|---|---|---|
| Accriva | Acquisition | 2017 | Werfen | S4 | |
| Adiana | Acquisition | 2007 | CYTYC | S4 | |
| AtheroMed | Acquisition | 2014 | Volcano Corporation | S4 | |
| Bacchus Vascular | Acquisition | 2009 | Covidien | S4 | |
| BDNA | Acquisition | 2017 | Flexera | S4 | |
| Broadlane | Acquisition | 2008 | Towerbrook | S4 | |
| CHF Solutions | Acquisition | 2010 | Gambro | S4 | |
| Concerro | Acquisition | 2012 | API Healthcare | S4 | |
| Emageon | Acquisition | 2009 | Merge Healthcare Solutions | S4 | |
| FreeClear | Acquisition | 2009 | Inverness Medical | S4 | |
| GeneOhm | Acquisition | 2016 | Becton Dickinson | S4 | |
| Health Dialog | Acquisition | 2007 | Bupa | S4 | |
| Hemosphere | Acquisition | 2012 | Cryolife | S4 | |
| NextHealth | Acquisition | 2022 | Softheon | S4 | |
| NextWeb | Acquisition | 2006 | Covad Communications | S4 |
Portfolio
The firm's portfolio page lists 71 companies: 23 active, 48 exited.S4
| Tag | Companies | Share |
|---|---|---|
| Active | 23 | 32.4% |
| Exited | 48 | 67.6% |
| Tag | Companies | Share |
|---|---|---|
| Information Technology | 28 | 39.4% |
| Services | 20 | 28.2% |
| Therapeutics | 13 | 18.3% |
| Diagnostics & Drug Delivery | 10 | 14.1% |
Every company on the Kaiser Permanente Ventures list
71 companies, as listed on the firm's own website: 48 exited, 23 active.S4 Read the firm's list.
Exited 48
- Accriva
- AcelRx
- Adiana
- Agile
- Astute Medical
- AtheroMed
- Bacchus Vascular
- BDNA
- Broadlane
- CHF Solutions
- Chrono
- Collective Medical Technologies
- Concerro
- DSI
- Emageon
- FreeClear
- GeneOhm
- Gynesonics
- Health Catalyst
- Health Dialog
- Hemosphere
- Ingenious Med
- iRhythm
- Kate Farms
- Kit Check
- NeoSeq
- NextHealth
- NextWeb
- Nordic Consulting Partners
- Nursefinders
- Nuvolo
- Optimal
- Oxford Immunotec
- Protenus
- Proteus
- Pulmonx
- SilverLink
- Talix
- Transcend
- Trivascular
- ValenTx
- Valeritas
- Validic
- Vapotherm
- Vesta Healthcare
- Vidyo
- Xanitos
- Zonare
Active 23
- Abridge
- Arine
- Big Health
- Clarium
- DexCare
- Everytable
- Freenome
- Garner Health
- Genome Medical
- Groups
- Headspace Health
- IntelyCare
- Leiters
- MetricStream
- Mind 24-7
- NOCD
- Omada
- Ordr
- Osso VR
- Rock Health
- Startup Health
- SureCo
- Wider Circle
Fund vehicles
| Vehicle | Size | Year | Note | Source |
|---|---|---|---|---|
| Fund V | USD 141M | 2019 | Closed Dec 2019; total assets under management above USD 500 million | S5 |
History
Where sources disagree
Official pages
Read the firm's own pages for current information.
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Kaiser Permanente Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.